Metastatic Carcinomas of the Breast

Earle W. Wilkins, John M. Head, John F. Burke, Pulmonary resection for metastatic neoplasms in the lung The American Journal of Surgery. ,vol. 135, pp. 480- 483 ,(1978) , 10.1016/0002-9610(78)90023-5

Henning Mouridsen, Mikhail Gershanovich, Yan Sun, Ramón Pérez-Carrión, Corrado Boni, Alain Monnier, Justus Apffelstaedt, Robert Smith, Harm P. Sleeboom, Fritz Jänicke, Anna Pluzanska, Magdolna Dank, Dominique Becquart, Poonamalle P. Bapsy, Eeva Salminen, Ray Snyder, Mercedes Lassus, J. Arnold Verbeek, Beatrix Staffler, Hilary A. Chaudri-Ross, Margaret Dugan, Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group Journal of Clinical Oncology. ,vol. 19, pp. 2596- 2606 ,(2001) , 10.1200/JCO.2001.19.10.2596

J.M. Nabholtz, A. Buzdar, M. Pollak, W. Harwin, G. Burton, A. Mangalik, M. Steinberg, A. Webster, M. von Euler, Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial Journal of Clinical Oncology. ,vol. 18, pp. 3758- 3767 ,(2000) , 10.1200/JCO.2000.18.22.3758

Michael Gershanovich, August Garin, Dace Baltina, Ants Kurvet, Lauri Kangas, Juha Ellmén, Eastern European Study Group, A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer Breast Cancer Research and Treatment. ,vol. 45, pp. 251- 262 ,(1997) , 10.1023/A:1005891506092

George W. Sledge, Donna Neuberg, Patricia Bernardo, James N. Ingle, Silvana Martino, Eric K. Rowinsky, William C. Wood, Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193) Journal of Clinical Oncology. ,vol. 21, pp. 588- 592 ,(2003) , 10.1200/JCO.2003.08.013

Harold J. Burstein, Lyndsay N. Harris, P. Kelly Marcom, Rosemary Lambert-Falls, Kathleen Havlin, Beth Overmoyer, Robert J. Friedlander, Janet Gargiulo, Rochelle Strenger, Charles L. Vogel, Paula D. Ryan, Mathew J. Ellis, Raquel A. Nunes, Craig A. Bunnell, Susana M. Campos, Michele Hallor, Rebecca Gelman, Eric P. Winer, Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm Journal of Clinical Oncology. ,vol. 21, pp. 2889- 2895 ,(2003) , 10.1200/JCO.2003.02.018

S Pyrhönen, R Valavaara, H Modig, M Pawlicki, T Pienkowski, S Gundersen, J Bauer, G Westman, S Lundgren, G Blanco, O Mella, I Nilsson, T Hietanen, I Hindy, J Vuorinen, A Hajba, Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study. British Journal of Cancer. ,vol. 76, pp. 270- 277 ,(1997) , 10.1038/BJC.1997.375

Jan GM Klijn, Louk VAM Beex, Louis Mauriac, Jacobus A van Zijl, Corinne Veyret, Johan Wildiers, Jacek Jassem, Martine Piccart, Jos Burghouts, Dominique Becquart, Carolien Seynaeve, Françoise Mignolet, Luc Duchateau, Combined Treatment With Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: a Randomized Study Journal of the National Cancer Institute. ,vol. 92, pp. 903- 911 ,(2000) , 10.1093/JNCI/92.11.903

Deborah Lindquist, Stephen Chan, C. Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman, Dimosthenis Skarlos, Mario Campone, Neville Davidson, Mark Berger, Cristina Oliva, Stephen D. Rubin, Steven Stein, David Cameron, Charles E. Geyer, John Forster, Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer The New England Journal of Medicine. ,vol. 355, pp. 2733- 2743 ,(2006) , 10.1056/NEJMOA064320

Charles L Vogel, Melody A Cobleigh, Debu Tripathy, John C Gutheil, Lyndsay N Harris, Louis Fehrenbacher, Dennis J Slamon, Maureen Murphy, William F Novotny, Michael Burchmore, Steven Shak, Stanford J Stewart, Michael Press, Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 20, pp. 719- 726 ,(2002) , 10.1200/JCO.20.3.719